[Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer 
Based on Molecular Subtyping].

Expert Committee on Tumor Biomarkers, Chinese Society of Clinical Oncology, Professional Committee of Onco-Respiratory Medicine, Zhejiang Anti-Cancer Association.

Open source

DOI
10.3779/j.issn.1009-3419.2026.102.18
Published
2026-07-01
Container
Zhongguo Fei Ai Za Zhi
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3779/j.issn.1009-3419.2026.102.18,
  title = {[Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer 
Based on Molecular Subtyping].},
  author = {Expert Committee on Tumor Biomarkers and  Chinese Society of Clinical Oncology and  Professional Committee of Onco-Respiratory Medicine and  Zhejiang Anti-Cancer Association.},
  year = {2026},
  journal = {Zhongguo Fei Ai Za Zhi},
  doi = {10.3779/j.issn.1009-3419.2026.102.18},
  url = {https://doi.org/10.3779/j.issn.1009-3419.2026.102.18}
}

RIS

TY  - JOUR
TI  - [Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer 
Based on Molecular Subtyping].
AU  - Expert Committee on Tumor Biomarkers
AU  -  Chinese Society of Clinical Oncology
AU  -  Professional Committee of Onco-Respiratory Medicine
AU  -  Zhejiang Anti-Cancer Association.
PY  - 2026
JO  - Zhongguo Fei Ai Za Zhi
DO  - 10.3779/j.issn.1009-3419.2026.102.18
UR  - https://doi.org/10.3779/j.issn.1009-3419.2026.102.18
ER  - 

APA

Biomarkers, E. C. O. T., Oncology, C. S. O. C., Medicine, P. C. O. O., & Association., Z. A. (2026). [Expert Consensus on Immunotherapy for Extensive-stage Small Cell Lung Cancer 
Based on Molecular Subtyping].. Zhongguo Fei Ai Za Zhi. https://doi.org/10.3779/j.issn.1009-3419.2026.102.18

Source records